In today’s episode, we explore Clinical Development with Ole Dammann, the owner of KFGN, a group of 6 clinical trial... more

In this conversation, I will talk with Peter Llewellyn-Davies, CEO of Apeiron and President of Biotech Austria about the Future... more

In this conversation, I will talk with Oliver Mavher and Michael Deichsel about Crypto Trading and taxes.Topics we discuss in... more

In this conversation, I will talk with Alexander Schwartz and Ingrid Kelly Spillmann about the future of the Early-Stage Ecosystem... more

The industry gains complexity, and I am happy that a speaker from the LSG2G community has dedicated time to speak... more

Tech Transfer describes the process to bring scientific inventions from the discovery stage into companies for translational and clinical R&D.To... more

In this conversation, we discuss the development of the European Pharma Eco-System, different business models generally accepted in the industry,... more

Here is my conversation with Andrea Sommer about the advantages of patents for private deep-tech companies.Timestamps:For those who want to... more

Here is my conversation with Kurt Höller and Joy Cürten from EIT Health about the health tech revolution in Europe... more

Here is my conversation with Sebastien Groyer, Entrepreneur and Venture CapitalistEpisode Links:Article to the Episode: https://lsg2g.substack.com/p/7-tales-from-20-years-of-deep-tech-42fYoutube: https://youtu.be/Ni3mEDM7-_cSebastien Groyer: https://www.linkedin.com/in/sebastien-groyer-2438548/Podcast Links:Podcast... more